MedCap AB (publ) (STO:MCAP)

MedCap AB Statistics

Total Valuation

MedCap AB has a market cap or net worth of SEK 9.76 billion. The enterprise value is 9.77 billion.

Market Cap	9.76B
Enterprise Value	9.77B

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	n/a

Share Statistics

MedCap AB has 15.04 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	15.04M
Shares Outstanding	15.04M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	3.87%
Owned by Institutions (%)	62.82%
Float	11.50M

Valuation Ratios

The trailing PE ratio is 48.94 and the forward PE ratio is 40.69.

PE Ratio	48.94
Forward PE	40.69
PS Ratio	5.13
PB Ratio	7.17
P/TBV Ratio	15.30
P/FCF Ratio	32.73
P/OCF Ratio	29.95
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.72, with an EV/FCF ratio of 32.75.

EV / Earnings	49.19
EV / Sales	5.13
EV / EBITDA	27.72
EV / EBIT	40.67
EV / FCF	32.75

Financial Position

The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.25.

Current Ratio	2.64
Quick Ratio	1.83
Debt / Equity	0.25
Debt / EBITDA	0.95
Debt / FCF	1.12
Interest Coverage	13.05

Financial Efficiency

Return on equity (ROE) is 15.95% and return on invested capital (ROIC) is 9.33%.

Return on Equity (ROE)	15.95%
Return on Assets (ROA)	7.54%
Return on Invested Capital (ROIC)	9.33%
Return on Capital Employed (ROCE)	13.97%
Revenue Per Employee	3.26M
Profits Per Employee	340,652
Employee Count	592
Asset Turnover	0.96
Inventory Turnover	2.77

Taxes

In the past 12 months, MedCap AB has paid 53.00 million in taxes.

Income Tax	53.00M
Effective Tax Rate	20.91%

Stock Price Statistics

The stock price has increased by +18.60% in the last 52 weeks. The beta is 0.50, so MedCap AB's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+18.60%
50-Day Moving Average	563.21
200-Day Moving Average	482.06
Relative Strength Index (RSI)	57.55
Average Volume (20 Days)	24,312

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedCap AB had revenue of SEK 1.90 billion and earned 198.60 million in profits. Earnings per share was 13.26.

Revenue	1.90B
Gross Profit	1.11B
Operating Income	240.20M
Pretax Income	253.50M
Net Income	198.60M
EBITDA	314.90M
EBIT	240.20M
Earnings Per Share (EPS)	13.26

Balance Sheet

The company has 335.10 million in cash and 335.10 million in debt.

Cash & Cash Equivalents	335.10M
Total Debt	335.10M
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	1.36B
Book Value Per Share	90.16
Working Capital	607.40M

Cash Flow

In the last 12 months, operating cash flow was 326.00 million and capital expenditures -27.70 million, giving a free cash flow of 298.30 million.

Operating Cash Flow	326.00M
Capital Expenditures	-27.70M
Free Cash Flow	298.30M
FCF Per Share	19.83

Margins

Gross margin is 58.16%, with operating and profit margins of 12.62% and 10.43%.

Gross Margin	58.16%
Operating Margin	12.62%
Pretax Margin	13.32%
Profit Margin	10.43%
EBITDA Margin	16.54%
EBIT Margin	12.62%
FCF Margin	15.67%

Dividends & Yields

MedCap AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	n/a
Earnings Yield	2.03%
FCF Yield	3.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.

Last Split Date	Sep 27, 2016
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	6